American Society for Clinical Pharmacology and Therapeutics 2019 Annual Meeting Pre-Conferences

Affiliations

¹ Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
² Quantitative Systems Pharmacology, Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
³ Division of Neuroscience, National Institute on Aging at the National Institutes of Health, Bethesda, Maryland, USA.
⁴ Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
⁵ Bill & Melinda Gates Foundation, Seattle, Washington, USA.

Editorial

Jane P F Bai et al. CPT Pharmacometrics Syst Pharmacol. 2019 Jun.

. 2019 Jun;8(6):333-335.

doi: 10.1002/psp4.12424. Epub 2019 Jun 4.

¹ Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
² Quantitative Systems Pharmacology, Early Clinical Development, Pfizer Inc, Cambridge, Massachusetts, USA.
³ Division of Neuroscience, National Institute on Aging at the National Institutes of Health, Bethesda, Maryland, USA.
⁴ Office of Research and Standards, Office of Generic Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
⁵ Bill & Melinda Gates Foundation, Seattle, Washington, USA.

No abstract available

Conflict of interest statement

The authors declared no competing interests for this work.

1. Walenga, R. et al In silico methods for development of generic drug‐device combination orally inhaled drug products (OIDPs). CPT Pharmacometrics Syst. Pharmacol. 10.1002/psp4.12413.[e-pub ahead of print]. - DOI - PMC - PubMed
1. Zhao, L. et al Current scientific considerations to verify physiologically based pharmacokinetic models and their implications for locally acting products. CPT Pharmacometrics Syst. Pharmacol. 8 (2019). - PMC - PubMed
1. National Institutes of Health Quantitative Systems Pharmacology Workshop Group et al Quantitative and Systems Pharmacology in the Post‐Genomic Era: New Approaches to Discovering Drugs and Understanding Therapeutic Mechanisms–An NIH White Paper by the QSP Workshop Group (National Institutes of Health, Bethesda, MD, 2011).
1. Nijsen, M. et al Preclinical QSP modeling in the pharmaceutical industry: an IQ consortium survey examining the current landscape. CPT Pharmacometrics Syst. Pharmacol. 7, 135–146 (2018). - PMC - PubMed
1. Zineh, I. Quantitative systems pharmacology: a regulatory perspective on translation. CPT Pharmacometrics Syst. Pharmacol. 10.1002/psp4.12403.[e-pub ahead of print] - DOI - PMC - PubMed